313 related articles for article (PubMed ID: 24891519)
21. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
[TBL] [Abstract][Full Text] [Related]
22. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
[TBL] [Abstract][Full Text] [Related]
23. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
Wulff H; Calabresi PA; Allie R; Yun S; Pennington M; Beeton C; Chandy KG
J Clin Invest; 2003 Jun; 111(11):1703-13. PubMed ID: 12782673
[TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.
Murray JK; Qian YX; Liu B; Elliott R; Aral J; Park C; Zhang X; Stenkilsson M; Salyers K; Rose M; Li H; Yu S; Andrews KL; Colombero A; Werner J; Gaida K; Sickmier EA; Miu P; Itano A; McGivern J; Gegg CV; Sullivan JK; Miranda LP
J Med Chem; 2015 Sep; 58(17):6784-802. PubMed ID: 26288216
[TBL] [Abstract][Full Text] [Related]
25. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide.
Kalman K; Pennington MW; Lanigan MD; Nguyen A; Rauer H; Mahnir V; Paschetto K; Kem WR; Grissmer S; Gutman GA; Christian EP; Cahalan MD; Norton RS; Chandy KG
J Biol Chem; 1998 Dec; 273(49):32697-707. PubMed ID: 9830012
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
[TBL] [Abstract][Full Text] [Related]
27. The Kv1.3 K
Varga Z; Tajti G; Panyi G
Biol Futur; 2021 Mar; 72(1):75-83. PubMed ID: 34554500
[TBL] [Abstract][Full Text] [Related]
28. Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK.
Pennington MW; Chang SC; Chauhan S; Huq R; Tajhya RB; Chhabra S; Norton RS; Beeton C
Mar Drugs; 2015 Jan; 13(1):529-42. PubMed ID: 25603346
[TBL] [Abstract][Full Text] [Related]
29. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Beeton C; Wulff H; Standifer NE; Azam P; Mullen KM; Pennington MW; Kolski-Andreaco A; Wei E; Grino A; Counts DR; Wang PH; LeeHealey CJ; S Andrews B; Sankaranarayanan A; Homerick D; Roeck WW; Tehranzadeh J; Stanhope KL; Zimin P; Havel PJ; Griffey S; Knaus HG; Nepom GT; Gutman GA; Calabresi PA; Chandy KG
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17414-9. PubMed ID: 17088564
[TBL] [Abstract][Full Text] [Related]
30. Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K
Sanches K; Prypoten V; Chandy KG; Chalmers DK; Norton RS
J Chem Inf Model; 2023 May; 63(10):3043-3053. PubMed ID: 37143234
[TBL] [Abstract][Full Text] [Related]
31. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
[TBL] [Abstract][Full Text] [Related]
32. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain.
Pennington MW; Mahnir VM; Krafte DS; Zaydenberg I; Byrnes ME; Khaytin I; Crowley K; Kem WR
Biochem Biophys Res Commun; 1996 Feb; 219(3):696-701. PubMed ID: 8645244
[TBL] [Abstract][Full Text] [Related]
33. Peptide blockers of K
Chandy KG; Norton RS
Curr Opin Chem Biol; 2017 Jun; 38():97-107. PubMed ID: 28412597
[TBL] [Abstract][Full Text] [Related]
34. The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model.
Gilhar A; Bergman R; Assay B; Ullmann Y; Etzioni A
J Invest Dermatol; 2011 Jan; 131(1):118-24. PubMed ID: 20739949
[TBL] [Abstract][Full Text] [Related]
35. Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
Chang SC; Galea CA; Leung EW; Tajhya RB; Beeton C; Pennington MW; Norton RS
Toxicon; 2012 Oct; 60(5):840-50. PubMed ID: 22659540
[TBL] [Abstract][Full Text] [Related]
36. Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model.
Ueyama A; Imura K; Kasai-Yamamoto E; Tai N; Nagira M; Shichijo M; Yasui K
Clin Exp Dermatol; 2013 Dec; 38(8):897-903. PubMed ID: 24252082
[TBL] [Abstract][Full Text] [Related]
37. Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile.
Middleton RE; Sanchez M; Linde AR; Bugianesi RM; Dai G; Felix JP; Koprak SL; Staruch MJ; Bruguera M; Cox R; Ghosh A; Hwang J; Jones S; Kohler M; Slaughter RS; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 2003 Nov; 42(46):13698-707. PubMed ID: 14622016
[TBL] [Abstract][Full Text] [Related]
38. A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmation.
Rashid MH; Heinzelmann G; Huq R; Tajhya RB; Chang SC; Chhabra S; Pennington MW; Beeton C; Norton RS; Kuyucak S
PLoS One; 2013; 8(11):e78712. PubMed ID: 24244345
[TBL] [Abstract][Full Text] [Related]
39. A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity.
Cotton J; Crest M; Bouet F; Alessandri N; Gola M; Forest E; Karlsson E; Castañeda O; Harvey AL; Vita C; Ménez A
Eur J Biochem; 1997 Feb; 244(1):192-202. PubMed ID: 9063464
[TBL] [Abstract][Full Text] [Related]
40. Targeting effector memory T-cells with Kv1.3 blockers.
Wulff H; Pennington M
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):438-45. PubMed ID: 17659485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
